Evercore ISI argues that Estee Lauder’s (EL) Clinique should be launched on Amazon (AMZN), pointing to L’Oreal’s (LRLCY) launch of Lancome on Amazon Premium Beauty and insight’s from Ulta‘s (ULTA) growth drivers – which “increasingly tile to mass and promotion” – to support the viewpoint. The firm has an Outperform rating and $200 price target on Estee Lauder shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EL:
- Estee Lauder Chairman Emeritus Leonard Lauder will not seek Board re-election
- Nvidia upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls
- Estee Lauder downgraded on ‘increasingly uncertain’ outlook at Bernstein
- Estee Lauder downgraded to Market Perform from Outperform at Bernstein
- Estée Lauder Stock (NYSE:EL): Bullish Options Flow Suggests Upside Potential